• Français
  • Search
  • Conference
    • CAHR 2023
    • Future CAHR Conferences
    • Mark Wainberg Lecture
    • Past Conferences
  • Awards
    • HCP Travel Awards Competition
    • Mark Wainberg Fund
    • CAHR-CANFAR Excellence in Research Awards
    • Red Ribbon Award
    • Funding Archive
    • Funding Landscape
  • Training
    • Workshops
    • Webinars
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada PART 2
    • Clinical Summaries
    • E-Learning Modules
    • Posters and Presentations
    • Community Based Research
    • Student Profiles
    • Training Workshops: Consultation Report
    • Publications / Resources
  • About CAHR
    • Who We Are
    • President’s Message
    • Board of Directors
    • Become a Member
    • CAHR Annual General Meeting
    • CAHR Strategic Plan 2020 – 2025
    • Staff
    • Contact
  • Media
    • CAHR News
    • Media
    • Featured Researchers
  • Conference
    • CAHR 2023
    • Future CAHR Conferences
    • Sponsors & Exhibitors
    • Mark Wainberg Lecture
    • Past Conferences
  • Awards
    • HCP Travel Awards Competition
    • Mark Wainberg Fund
    • CAHR-CANFAR Excellence in Research Awards
    • Red Ribbon Award
    • Funding Archive
    • Funding Landscape
  • Training
    • Workshops
    • Webinars
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada
      • HIV and COVID-19: Clinical Considerations for Health Care Professionals in Canada PART 2
    • Clinical Summaries
    • E-Learning Modules
    • Posters and Presentations
    • Community Based Research
    • Student Profiles
    • Training Workshops: Consultation Report
    • Publications / Resources
  • About CAHR
    • Who We Are
    • President’s Message
    • Board of Directors
    • CAHR Board Trainee
    • Become a Member
    • CAHR Strategic Plan 2020 – 2025
    • CAHR Annual General Meeting
    • Call for Nominations: CAHR Board of Directors
    • Staff
    • Contact
  • Media
    • CAHR News
    • Media

Peter Quashie

Having spent his school years in Botswana, Peter Quashie was familiar with the toll AIDS was taking in the community around him. By high school, the Ghana native had already decided that if he had the opportunity, he would be a researcher and seek a cure for HIV/AIDS.

“That was the only thing that I wanted to do,” he says.

Flash forward to 2012, and Quashie is fulfilling his dream, carrying out his doctoral research in the McGill University lab of Dr. Mark Wainberg, one of the world’s pre-eminent HIV researchers, with the support of a CAHR Doctoral Research Award. (He chose Dr. Wainberg’s lab based on his research interest, incidentally, not even knowing what a fundamental figure the Canadian researcher is – “I didn’t know how big he was,” Quashie says.)

Quashie’s research focuses on drug resistance to HIV treatment. One of the main ways drugs act to prevent the progression of HIV is by interfering with the insertion of the HIV genome into the host genome, using a class of drugs called integrase inhibitors. HIV, ever wily, has figured out how to bypass the first-generation HIV integrase inhibitors, becoming resistant to their action, so Quashie is focusing his efforts on the second-generation drugs. His hypothesis is that the second-generation drugs inhibit HIV integration in a different way. He is trying to find mutations in HIV that make it resistant to these second-generation drugs, in the hope that it might, one day, lead to the development of even more effective treatments for HIV.

For Quashie, that is one of the benefits of working in Dr. Wainberg’s lab – he has freedom in choosing his research topic, but Dr. Wainberg keeps everyone’s focus strictly on the clinic.

“It’s lab-based work, but it’s also viable in the clinical setting,” says Quashie of his research. “As we formulate our hypothesis, we’re always thinking about the clinical aspects.”

“Our research revolves very strongly around HIV drug resistance and obviously that’s a clinically relevant area,” says Dr. Wainberg. “Peter is very much in the thick of this. He’s a great student and does excellent work.”

Having a CAHR Doctoral Research Award has played a major role in Quashie’s success to date. It’s enabled him to focus on his research, rather than being a teaching assistant, and it’s enabled him to attend conferences such as the Fourth International Conference on Retroviral Integration, held in Italy in fall 2011. It’s also enabled him to collaborate with his colleagues in the Wainberg lab, helping Quashie to build the elements of a research career, such as publications and other measures of research impact.

While he’s focused on drug resistance right now, Quashie’s ultimate goal remains to find a cure for HIV/AIDS, and that’s where he plans on spending his time once finished his PhD. And, despite the obstacles standing in the way of a cure, Quashie believes that one will be found – or even more likely, a multitude of cures that work in different ways.

“I wouldn’t say no [to the possibility of a cure],” he says. “But I would not be able to put a time frame on that.”

Our Mission

  • Promote excellence in HIV research
  • Foster collaboration and cooperation among HIV research communities, including basic science, clinical science, epidemiology & public health and social science
  • Promote education and the development of new researchers
  • Provide a unified voice for Canadian HIV researchers and engage diverse stakeholders (community, industry, Government, NGO’s etc.) in ongoing dialogue and knowledge exchange to ensure that HIV research remains responsive to their needs
CAHR 2023 Conference Logo

CAHR 2023
April 27 to 30, 2023

Learn More

Recent News

  • When you’re registering for the e @AMMICana - CACMID annual conference on infectious diseases and diagnostic microbiology (March 28-31, 2023 in Toronto), remember that CAHR members receive a $35 discount on the full non-member conference registration! ammi.ca/en/annual-conf…
  • Last day to apply for the CAHR-@CANFAR Excellence in Research Awards! cahr-acrv.ca/awards/excelle… Dernier jour pour postuler aux Bourses d'excellence en recherche CAHR-@CANFAR! cahr-acrv.ca/fr/prix/prix-d… https://t.co/szhBdhZuRZ
  • Remember to apply for the CAHR-RV-@CAN Excellence in Research Awards by January 26th! cahr-acrv.ca/awards/excelle… Après le 26 janvier nous n’acceptons plus de candidatures aux Prix d'excellence en recherche ACRV-RV-@CAN! cahr-acrv.ca/fr/prix/prix-d… https://t.co/bhgkCEDBmD
  • Reminder: Apply Now – A workshop on “Jumpstarting your Participatory Social-Behavioural Health Intervention” cahr-acrv.ca/wp-content/upl… UmnUV @CBRC weets @CAT EInfo @Giving_
  • Rappel : Postulez maintenant - Un atelier sur « Lancez votre intervention participative en santé sociocomportementale ». cahr-acrv.ca/wp-content/upl… ZS @CBRCtwe ts @CATIEI fo @Giving_It_
  • Se souvenir de Chris Bunting
Subscribe to the CAHR Newsletter

About CAHR

With a membership of more than 1,000 researchers and others interested in HIV research, the Canadian Association for HIV Research (CAHR) is the leading organization of HIV/AIDS researchers in Canada. CAHR is the organizing body for the Annual Canadian Conference on HIV/AIDS Research (CAHR Conference).

CAHR encourages Canadian researchers to be leaders in knowledge translation and to effectively respond both to the Canadian and global HIV/AIDS epidemics. Since its founding in 1991, CAHR has promoted excellence in HIV research, including mentorship and career development of investigators entering the field.

CAHR fosters collaboration and co-operation among HIV research communities, including basic, clinical and social sciences, epidemiology and public health. CAHR also engages people living with HIV/AIDS and AIDS service organizations in ongoing dialogue and information exchange to ensure that HIV/AIDS research remains responsive to the epidemic and its stakeholders.

CAHR is a registered charity.

Links

  • Who We Are
  • Conference
  • Awards
  • Workshops
  • Featured Researchers
  • Student Profiles
  • CAHR News

Contact

For more information or to make a comment, please contact us:

Canadian Association for HIV Research

440 Laurier Avenue West, Suite 200
Ottawa, Ontario K1R 7X6

1-888-374-CAHR (2247)
info@cahr-acrv.ca
  • Media
  • Contact
  • Français